IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROMANI, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.273
EU - Europa 1.579
AS - Asia 803
SA - Sud America 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 5.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.251
PL - Polonia 590
CN - Cina 344
IT - Italia 258
UA - Ucraina 232
DE - Germania 185
SG - Singapore 172
HK - Hong Kong 131
FI - Finlandia 109
IE - Irlanda 58
GB - Regno Unito 56
TR - Turchia 55
VN - Vietnam 44
EE - Estonia 23
FR - Francia 22
ID - Indonesia 22
CA - Canada 19
SE - Svezia 18
IN - India 12
BE - Belgio 8
CZ - Repubblica Ceca 7
AU - Australia 5
KR - Corea 5
BR - Brasile 4
TW - Taiwan 4
BG - Bulgaria 3
EU - Europa 3
KG - Kirghizistan 3
MX - Messico 3
RU - Federazione Russa 3
AR - Argentina 2
AZ - Azerbaigian 2
IQ - Iraq 2
LK - Sri Lanka 2
LT - Lituania 2
NL - Olanda 2
AT - Austria 1
BY - Bielorussia 1
EG - Egitto 1
JP - Giappone 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MU - Mauritius 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.671
Salva come PNG Salva come JPEG
Città #
Warsaw 588
Fairfield 466
Woodbridge 328
Houston 269
Ashburn 246
Chandler 241
Seattle 216
Jacksonville 175
Wilmington 165
Cambridge 143
Singapore 142
New York 130
Ann Arbor 128
Hong Kong 112
Dearborn 106
Princeton 101
Brescia 80
Helsinki 76
Nanjing 62
Dublin 58
Istanbul 53
Beijing 47
Dong Ket 44
Shanghai 43
Los Angeles 36
Milan 30
Tallinn 23
Jakarta 22
San Diego 21
Shenyang 20
Jinan 19
London 18
Toronto 18
Nanchang 17
Central 14
Kunming 14
Tianjin 14
Changsha 13
Hebei 13
Des Moines 12
Jiaxing 12
Hangzhou 10
Monmouth Junction 10
Munich 10
Rome 10
Zhengzhou 8
Brussels 7
Leawood 7
Norwalk 7
Pune 6
Boardman 5
Brno 5
Kilburn 5
Lappeenranta 5
Romola 5
Washington 5
Brembate di Sopra 4
Cazzago San Martino 4
Guangzhou 4
Hefei 4
Ningbo 4
Phoenix 4
San Mateo 4
Verona 4
Arezzo 3
Bishkek 3
Lancaster 3
Lanzhou 3
New Bedfont 3
North 3
Orange 3
San Francisco 3
Sofia 3
Taizhou 3
Taoyuan District 3
Augusta 2
Baghdad 2
Bagheria 2
Baton Rouge 2
Berlin 2
Buenos Aires 2
Chengdu 2
Cheongju-si 2
Clifton 2
Colombo 2
Dallas 2
Espoo 2
Exeter 2
Ferrara 2
Fort Worth 2
Fuzhou 2
Gualdo Tadino 2
Gunzenhausen 2
Islington 2
Melbourne 2
Mexico City 2
Neustadt an der Aisch 2
Newark 2
Olomouc 2
Paris 2
Totale 4.555
Salva come PNG Salva come JPEG
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 288
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 264
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 259
Claudin3 is localized outside the tight junctions in human carcinomas 233
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 226
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 157
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 149
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 147
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 144
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 140
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 140
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 140
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 139
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 135
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 130
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 130
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 129
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 123
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 122
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 119
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 117
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 115
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 114
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 111
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 111
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 110
Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. 89
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 88
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 87
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. 84
Human papillomavirus type 16 (HPV-16) virus-like particleL1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. 81
HE4 and epithelial ovarian cancer : Comparison and clinical evaluation of two immunoassays and a combination algorithm 81
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 79
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 77
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 76
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 74
OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE-1 RECEPTOR (EGF-R1) IN CERVICAL CANCER: IMPLICATIONS FOR CETUXIMAB-MEDIATED THERAPY IN RECURRENT/METASTATIC DISEASE. 73
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 70
Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma: Implications for Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal Antibody 69
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 62
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 61
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 57
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 55
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 55
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 48
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 45
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 43
Integrated mutational landscape analysis of uterine leiomyosarcomas 34
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 34
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer 34
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 30
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 30
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies 29
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 29
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 27
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 27
Finding the junction between claudins and endometrial carcinoma 22
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 21
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 20
HPV16VLP L1-Specific CD8+ cytotoxic T lymphocytes (CTL) are equally effective as E7-specific CD8+ CTL in killing autologous HPV16 positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines 14
Mammaglobin B (SCGB2A1) is a novel tumor antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy 11
The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives 8
Totale 5.816
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020919 0 0 0 0 95 185 164 145 107 122 38 63
2020/2021924 22 77 29 125 39 85 53 103 98 135 86 72
2021/2022544 64 92 11 3 5 32 48 28 26 97 38 100
2022/2023611 90 38 32 40 60 126 8 66 84 6 35 26
2023/2024775 38 25 78 56 43 189 45 45 124 44 15 73
2024/2025455 28 41 29 246 111 0 0 0 0 0 0 0
Totale 5.816